News | September 12, 2007

Numa Introduces NumaStore Lite at ASNC 07

September 13, 2007 - Numa, a nuclear medicine connectivity company, introduced NumaStore Lite Image Management Solution for nuclear cardiology, PET and today’s multimodality images, at the American Society of Nuclear Cardiology, Sept. 6 to Sept. 9, in San Diego, CA.

NumaStore Lite is a special version of Numa’s image storage and management system that is fine-tuned for the needs of smaller NM departments, freestanding clinics and specialty practices using NM images, such as nuclear cardiology.

Traditional NumaStore offers secure cataloging and long-term storage of NM, PET/CT and related patient studies. Enabling a paradigm shift in use of NM studies, it also supports efficient retrieval of these studies for long-term patient care as an alternative to the simple diagnostic snapshots stored on a PACS that are used today.

New NumaStore Lite is appropriate for the specialized workflow and lower volume storage needs of smaller practices, while offering enhanced cost efficiencies.

For more information: www.numa-inc.com

Related Content

Researchers Trace Parkinson’s Damage in the Heart
News | PET Imaging | July 17, 2018
A new way to examine stress and inflammation in the heart will help Parkinson’s researchers test new therapies and...
Siemens Healthineers Announces FDA Clearance of syngo.via VB30 Molecular Imaging Software
Technology | Nuclear Imaging | July 16, 2018
At the 2018 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 23-26 in Philadelphia...
Sponsored Content | Whitepapers | PACS | July 09, 2018
The move toward value-based reimbursement (VBR) models is putting pressure on healthcare organizations to modernize...
Sponsored Content | Case Study | PACS | July 09, 2018
One of the Northeast’s major teaching hospitals is an international leader in virtually every area of medicine. It has...
SNMMI Image of the Year Highlights Theranostic Approach for Advanced Prostate Cancer

IMAGE OF THE YEAR: PSMA PET before and after lutetium-177 PSMA617 theranostics in 8 patients with metastatic prostate cancer who exhausted standard therapeutic options.

68Ga-PSMA11 PET maximum intensity projection (MIP) images at baseline and 3 months after 177Lu-PSMA617 in 8 patients with PSA decline ≥ 98 percent in a prospective phase II study. Any disease with SUV over 3 is in red. Credit: Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Sue Ping Thang, Price Jackson, Mark Scalzo, Scott Williams and Rodney Hicks, Peter MacCallum Cancer Centre, Melbourne, Australia.

News | PET Imaging | June 29, 2018
In the battle against metastatic castrate-resistant prostate cancer, studies have demonstrated a high response rate to...
MILabs Introduces Futuristic PET Capabilities on New VECTor6 System
Technology | PET Imaging | June 28, 2018
At the 2018 Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting, June 23-26, in Philadelphia,...
Philips North America and GE Healthcare Win IMV PET Imaging ServiceTrak Awards
News | PET Imaging | June 25, 2018
IMV, part of the Science and Medicine Group and a market research and business intelligence provider to the imaging...
New ASNC SPECT Imaging Guideline Addresses Advances in Myocardial Perfusion Imaging
News | SPECT Imaging | June 21, 2018
The American Society of Nuclear Cardiology (ASNC) has published an update to its 2010 guidelines for single photon...
FDA Clears New Imaging Functionalities for Biograph mCT PET/CT Systems
Technology | PET-CT | June 21, 2018
Siemens Healthineers will announce U.S. Food and Drug Administration (FDA) clearance of four new system features for...
Overlay Init